1. Home
  2. UP vs EBS Comparison

UP vs EBS Comparison

Compare UP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$0.52

Market Cap

476.3M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.19

Market Cap

434.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
EBS
Founded
2013
1998
Country
United States
United States
Employees
1866
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
476.3M
434.4M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
UP
EBS
Price
$0.52
$8.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
0.93
Revenue
N/A
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.62
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$4.02
52 Week High
$3.50
$14.06

Technical Indicators

Market Signals
Indicator
UP
EBS
Relative Strength Index (RSI) 41.12 36.43
Support Level $0.49 $7.66
Resistance Level $0.59 $9.28
Average True Range (ATR) 0.04 0.30
MACD 0.00 0.08
Stochastic Oscillator 29.21 50.00

Price Performance

Historical Comparison
UP
EBS

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: